Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helgo Magnussen

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|September 9, 2014
Withdrawal of inhaled glucocorticoids and exacerbations of COPDHelgo Magnussen, Bernd Disse, Roberto Rodriguez-Roisin, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Emiel F M Wouters, et al.
Plos One|June 16, 2012
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityDebra A Cockayne, Donavan T Cheng, Benjamin Waschki, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2008
Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanismsShinsaku Togo, Olaf Holz, Xiangde Liu, et al.
American Journal of Respiratory Cell and Molecular Biology|October 9, 2012
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4Joel Michalski, Nobuhiro Kanaji, Xiangde Liu, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 19, 2006
[Guidelines for diagnosis and therapy of patients with asthma 2005. The most important aspects for adults]Gerhard Schultze-Werninghaus, Peter Kardos, Dietrich Berdel, et al.
Respiratory Medicine|November 29, 2011
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter studyBenjamin Waschki, Martijn A Spruit, Henrik Watz, et al.
American Journal of Respiratory Cell and Molecular Biology|February 3, 2012
Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblastsMasanori Nakanishi, Tadashi Sato, Yingji Li, et al.
Respiratory Research|September 10, 2021
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONETChristina Kellerer, Rudolf A Jörres, Antonius Schneider, et al.
American Journal of Respiratory and Critical Care Medicine|August 18, 2016
Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network StudySarah Houben-Wilke, Rudolf A Jörres, Robert Bals, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|September 9, 2014
Withdrawal of inhaled glucocorticoids and exacerbations of COPDHelgo Magnussen, Bernd Disse, Roberto Rodriguez-Roisin, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Emiel F M Wouters, et al.
Plos One|June 16, 2012
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityDebra A Cockayne, Donavan T Cheng, Benjamin Waschki, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2008
Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanismsShinsaku Togo, Olaf Holz, Xiangde Liu, et al.
American Journal of Respiratory Cell and Molecular Biology|October 9, 2012
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4Joel Michalski, Nobuhiro Kanaji, Xiangde Liu, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 19, 2006
[Guidelines for diagnosis and therapy of patients with asthma 2005. The most important aspects for adults]Gerhard Schultze-Werninghaus, Peter Kardos, Dietrich Berdel, et al.
Respiratory Medicine|November 29, 2011
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter studyBenjamin Waschki, Martijn A Spruit, Henrik Watz, et al.
American Journal of Respiratory Cell and Molecular Biology|February 3, 2012
Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblastsMasanori Nakanishi, Tadashi Sato, Yingji Li, et al.
Respiratory Research|September 10, 2021
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONETChristina Kellerer, Rudolf A Jörres, Antonius Schneider, et al.
American Journal of Respiratory and Critical Care Medicine|August 18, 2016
Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network StudySarah Houben-Wilke, Rudolf A Jörres, Robert Bals, et al.
Pageof 13